Incobotulinum Toxin A – March 2026

Lyophilised powder for injection 100 units

Brand names:
- Xeomin®
Pharmaceutical Company:
- MERZ AUSTRALIA PTY LTD
Condition/Indication: Moderate to severe spasticity of the lower limb in adults following an acute event
Meeting Date: March 2026

Public Summary Documents

Last updated

11 March 2026